Session 2 – INDUSTRY CONCERNS AND REMEDIES

ACCI 2017 Session 2

Session 2 – INDUSTRY CONCERNS AND REMEDIES

768 512 admin

Session 2 brought up the points of the taxes being levied on machines used in cancer care, manufacturing outside India leading to increased cost of machines, orphan drug relevance and the requirement of biosimilars. The conclusion reached was that taxation on the machines should be reduced or removed, manufacture of those machines should move to India as joint ventures, change in orphan drug policy and the need for increased biosimilar production.